MUC16-mediated activation of mTOR and c-MYC reprograms pancreatic cancer metabolism
MUC16, a transmembrane mucin, facilitates pancreatic adenocarcinoma progression and metastasis. In the current studies, we observed that MUC16 knockdown pancreatic cancer cells exhibit reduced glucose uptake and lactate secretion along with reduced migration and invasion potential, which can be rest...
Main Authors: | Shukla, Surendra K., Gunda, Venugopal, Abrego, Jaime, Haridas, Dhanya, Mishra, Anusha, Souchek, Joshua, Chaika, Nina V., Yu, Fang, Sasson, Aaron R., Lazenby, Audrey J., Batra, Surinder K., Singh, Pankaj K. |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662479/ |
Similar Items
-
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
by: Shukla, Surendra K., et al.
Published: (2015) -
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
by: Shukla, Surendra K, et al.
Published: (2014) -
Correction: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
by: Shukla, Surendra K, et al.
Published: (2014) -
mTOR, autophagy, and reprogramming
by: Tang, Bor Luen
Published: (2014) -
Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer
by: Seshacharyulu, Parthasarathy, et al.
Published: (2014)